Filgotinib, a JAK1 Inhibitor, Modulates Disease-Related Biomarkers in Rheumatoid Arthritis: Results From Two Randomized, Controlled Phase 2b Trials

Rheumatology and Therapy
doi 10.1007/s40744-019-00192-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Upadacitinib and Filgotinib: The Role of JAK1 Selective Inhibition in the Treatment of Rheumatoid Arthritis

Drugs in Context
Molecular MedicinePharmacology
2019English

Upadacitinib and Filgotinib: The Role of JAK1 Selective Inhibition in the Treatment of Rheumatoid Arthritis

Drugs in Context
Molecular MedicinePharmacology
2019English

FRI0428 the JAK1-selective Inhibitor, Filgotinib, Inhibits Inflammation Pathways Observed in an IL23-induced Psoriatic Arthritis Mouse Model

2017English

B Cells in Rheumatoid Arthritis: From Pathogenic Players to Disease Biomarkers

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2014English

How Should a Clinician Interpret Results of Randomized Controlled Trials?: Interpretation of Randomized Controlled Trials

Acta medica Lituanica
2010English

Impact of Tocilizumab Monotherapy on Patient-Reported Outcomes in Patients With Rheumatoid Arthritis From Two Randomised Controlled Trials

RMD Open
RheumatologyAllergyImmunology
2017English

Chemerin and PEDF Are Metaflammation-Related Biomarkers of Disease Activity and Obesity in Rheumatoid Arthritis

Frontiers in Medicine
Medicine
2018English

Cost-Effectiveness of a JAK1/JAK2 Inhibitor vs a Biologic Disease-Modifying Antirheumatic Drug (bDMARD) in a Treat-To-Target Strategy for Rheumatoid Arthritis

ClinicoEconomics and Outcomes Research
Health PolicyEconomicsEconometricsFinance
2020English

Biologic Refractory Disease in Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy